Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 11;10(10):CD008032.
doi: 10.1002/14651858.CD008032.pub3.

Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months

Zohra S Lassi  1 , Aamer Imdad, Zulfiqar A Bhutta
Affiliations

Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months

Zohra S Lassi et al. Cochrane Database Syst Rev. .

Abstract

Background: Pneumonia is a leading cause of childhood mortality from infectious disease, responsible for an estimated 1.3 million deaths annually in children under five years of age, many of which are in low-income countries. The World Health Organization recommends intravenous antibiotics for five days as first-line treatment for children with severe pneumonia. Although controversy exists regarding the specific clinical features used to diagnose pneumonia, the criteria for diagnosis of severe pneumonia are better defined and are widely used to triage children for referral and second-line therapy.In 2011 it was estimated that approximately 120 million new cases of pneumonia occur globally each year in children under five years of age, of which 14 million become severe episodes. Hospitalisation for severe pneumonia in children places a significant burden on both patients and their families, including substantial expense, loss of routine, and decrease in quality of life. By reducing the duration of hospital treatment, healthcare burdens could potentially be reduced and treatment compliance may improve.This is an update of a review published in 2015.

Objectives: To evaluate the efficacy of short-course (two to three days) versus long-course (five days) intravenous therapy (alone or in combination with oral antibiotics) with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 12), MEDLINE (1966 to December week 3, 2016), Embase (1974 to 22 December 2016), and four trials registers (23 August 2017), together with reference checking of all relevant trials and reviews.

Selection criteria: Randomised controlled trials evaluating the efficacy of short-course (two to three days) versus long-course (five days) intravenous antibiotic therapy (alone or in combination with oral antibiotics) for severe pneumonia in children aged two months to 59 months. We excluded children with any other debilitating disease, including those infected with HIV. We also excluded children who had developed pneumonia during their hospital stay (i.e. with nosocomial infection). There was no restriction on the type of antibiotic used, the dose, or the frequency of dosing.

Data collection and analysis: We used standard methodological procedures expected by Cochrane.

Main results: Our searches identified 4295 records, however no studies met our predefined inclusion criteria.

Authors' conclusions: We identified no randomised controlled trials comparing a short course (two to three days) of intravenous antibiotics compared to a long course (five days) for severe pneumonia in children aged two months to 59 months that met our inclusion criteria.

PubMed Disclaimer

Conflict of interest statement

Zohra S Lassi: None known. Aamer Imdad: None known. Zulfiqar A Bhutta: None known.

Figures

1
1
Study flow diagram
See this image and copyright information in PMC

Update of

References

References to studies excluded from this review

Greenberg 2014 {published and unpublished data}
    1. Greenberg D, Ben‐Shimol S, Zdaka Y, Givon‐Lavi N, Dagan R. Short antibiotic treatment (Rx) for community‐acquired alveolar pneumonia (CAAP) in children ‐ a double blinded, randomized trial. 48th Annual Meeting of Infectious Disease Society of America (IDSA), 2010 October 21‐24. Vancouver, Canada. 2010. [Abstract No 514]
    1. Greenberg D, Givon‐Lavi N, Sadaka Y, Ben‐Shimol S, Bar‐Ziv J, Dagan R. Short‐course antibiotic treatment for community‐acquired alveolar pneumonia in ambulatory children: a double‐blind, randomized, placebo‐controlled trial. Pediatric Infectious Disease Journal 2014;33(2):136‐42. - PubMed

Additional references

AFRINEST 2015a
    1. African Neonatal Sepsis Trial (AFRINEST) group, Tshefu A, Lokangaka A, Ngaima S, Engmann C, Esamai F, et al. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open‐label, equivalence trial. Lancet 2015; Vol. 385, issue 9979:1758‐66. [DOI: 10.1016/S0140-6736(14)62285-6] - DOI - PubMed
AFRINEST 2015b
    1. African Neonatal Sepsis Trial (AFRINEST) group, Tshefu A, Lokangaka A, Ngaima S, Engmann C, Esamai F, et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open‐label, equivalence trial. Lancet 2015; Vol. 385, issue 9979:1767‐76. [DOI: 10.1016/S0140-6736(14)62284-4] - DOI - PubMed
Ashraf 2008
    1. Ashraf H, Jahan SA, Alam NH, Mahmud R, Kamal SM, Salam MA, et al. Day‐care management of severe and very severe pneumonia, without associated co‐morbidities such as severe malnutrition, in an urban health clinic in Dhaka, Bangladesh. Archives of Disease in Childhood 2008;93(6):490‐4. - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. - PMC - PubMed
Baqui 2015
    1. Baqui AH, Saha SK, Ahmed AS, Shahidullah M, Quasem I, Roth DE, et al. Projahnmo Study Group in Bangladesh. Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open‐label, equivalence trial. Lancet Global Health 2015; Vol. 3, issue 5:e279‐87. [DOI: 10.1016/S2214-109X(14)70347-X] - DOI - PubMed
Boluyt 2008
    1. Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Archives of Pediatrics and Adolescent Medicine 2008;162(2):111‐6. - PubMed
Campbell 1995
    1. Campbell H. Acute respiratory infection: a global challenge. Archives of Disease in Childhood 1995;73(4):281‐6. - PMC - PubMed
Chowdhury 2008
    1. Chowdhury EK, Arifeen S, Rahman M, Hoque DE, Hossain MA, Begum K, et al. Care at first‐level facilities for children with severe pneumonia in Bangladesh: a cohort study. Lancet 2008;372(9641):822‐30. - PubMed
Durbin 2008
    1. Durbin WJ, Stille C. Pneumonia. Pediatrics in Review 2008;29(5):147‐58. - PubMed
Fox 2015
    1. Fox MP, Baqui AH, Hibberd PL, Black RE, Santosham M, Bhutta Z, et al. Antibiotic trials for community‐acquired pneumonia. Lancet Respiratory Medicine 2015;3(3):e4‐5. - PubMed
Gaston 2002
    1. Gaston B. Pneumonia. Pediatric Reviews 2002;23(4):132‐40. - PubMed
GRADEpro GDT 2015 [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version (accessed prior to 27 July 2017). Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Graham 2008
    1. Graham SM, English M, Hazir T, Enarsond P, Duke T. Challenges to improving case management of childhood pneumonia at health facilities in resource‐limited settings. Bulletin of the World Health Organization 2008;86(5):349‐55. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at handbook.cochrane.org.
Hussain 2006
    1. Hussain H, Waters H, Omer SB, Khan A, Baig IY, Mistry R, et al. The cost of treatment for child pneumonias and meningitis in the northern areas of Pakistan. International Journal of Health Planning and Management 2006;21(3):229‐38. - PubMed
Jadavji 1997
    1. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold E, Wang EE. A practical guide for the diagnosis and treatment of pneumonia. CMAJ: Canadian Medical Association Journal 1997;156(5):S703‐11. - PMC - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Marsh 2008
    1. Marsh DR, Gilroy KE, Weerdt R, Wansi E, Qazi S. Community case management of pneumonia: at a tipping point?. Bulletin of the World Health Organization 2008;86(5):321‐416. - PMC - PubMed
Omidvari 1998
    1. Omidvari K, Boisblanc BP, Karam G, Nelson S, Haponik E, Summer W. Early transition to oral antibiotic therapy for community‐acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis. Respiratory Medicine 1998;92(8):1032‐9. - PubMed
Ostapchuk 2004
    1. Ostapchuk M, Roberts DM, Haddy R. Community‐acquired pneumonia in infants and children. American Family Physician 2004;70:899‐908. - PubMed
Qazi 2015
    1. Qazi S, Were W. Improving diagnosis of childhood pneumonia. Lancet Infectious Diseases 2015;15(4):372‐3. - PubMed
Rambaud‐Althaus 2015
    1. Rambaud‐Althaus C, Althaus F, Genton B, D'Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta‐analysis. Lancet Infectious Diseases 2015;15(4):439–50. - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rojas‐Reyes 2006
    1. Rojas‐Reyes MX, Granados Rugeles C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD004979.pub2] - DOI - PMC - PubMed
Shoham 2005
    1. Shoham Y, Dagan R, Givon‐Lavi N, Liss Z, Shagan T, Zamir O, et al. Community‐acquired pneumonia in children: quantifying the burden on patients and their families including decrease in quality of life. Pediatrics 2005;115(5):1213‐9. - PubMed
UNICEF/WHO 2006
    1. UNICEF/WHO. Pneumonia: the forgotten killer of children. apps.who.int/iris/bitstream/10665/43640/1/9280640489_eng.pdf. (accessed prior to 27 July 2017) 2006.
Walker 2013
    1. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381(9875):1405‐16. - PMC - PubMed
WHO 1991
    1. World Health Organization. Programme of Acute Respiratory Infections. Technical bases for the WHO recommendations on the management of pneumonia in children at first‐level health facilities (1991). apps.who.int/iris/handle/10665/61199 (accessed prior to 27 July 2017).
WHO 2005
    1. World Health Organization. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources (2005). apps.who.int/iris/bitstream/10665/43206/1/9241546700.pdf. Geneva, Switzerland: World Health Organization, (accessed prior to 27 July 2017).
WHO 2013
    1. World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses (2nd edition, 2013). apps.who.int/iris/bitstream/10665/81170/1/9789241548373_eng.pdf (accessed prior to 27 July 2017). - PubMed
WHO 2014
    1. World Health Organization. Revised WHO classification and treatment of childhood pneumonia at health facilities: evidence summaries (2014). apps.who.int/iris/bitstream/10665/137319/1/9789241507813_eng.pdf. Geneva, Switzerland: World Health Organization, (accessed prior to 27 July 2017).
Zar 2013
    1. Zar HJ, Madhi SA, Aston SJ, Gordon SB. Pneumonia in low and middle income countries: progress and challenges. Thorax 2013;68:1052‐6. - PMC - PubMed

References to other published versions of this review

Lassi 2015
    1. Lassi ZS, Imdad A, Bhutta ZA. Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD008032.pub2] - DOI - PubMed
Zaidi 2009
    1. Zaidi A, Haider BA, Bhutta ZA. Short course versus long course intravenous therapy of the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008032] - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources